Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
abeyance, adhere, arisen, arose, Brazilian, broken, carbonic, CODM, consummated, CRL, deepening, detailed, disaggregated, dividend, durable, EGC, Erroneously, Gaza, impracticable, Indenture, Loqtorzi, merger, modification, multi, noncash, partner, pre, prefunded, proactively, reassessed, reconciling, Recovery, regularly, resubmission, reverting, SG, Simplification, tabular, team, trotabresib, undetected, unexercised, unissued, unregistered
Removed:
accountant, Aid, almonertinib, assumed, BDO, billion, carryback, comparison, computing, constrained, Corporation, correspondingly, deduction, deferment, dosed, employer, entertainment, EQRx, expensing, filer, Founder, irrevocable, Leap, nonbinding, NY, opt, opted, payroll, Pharma, promissory, purpose, refundable, retaining, revised, shareholder, substantive, timeline, unaudited, USA, York, young
Filing tables
Filing exhibits
Related press release
CKPT similar filings
Filing view
External links
| | |
| | Exhibit 23.1 |
| | |
| KPMG LLP Two Financial Center 60 South Street Boston, MA 02111 | |
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the registration statements (Nos. 333-270474, 333-270474, 333-270843, 333-271171, 333-275644) on Form S-3 and (Nos. 333-216856, 333-221488, 333-251000, 333-268740, 333-275643) on Form S-8 of our report dated March 22, 2024, with respect to the financial statements of Checkpoint Therapeutics, Inc.
/s/ KPMG LLP
Boston, Massachusetts
March 22, 2024